NEW YORK (GenomeWeb News) – Cellular Dynamics today said that it has licensed exclusive rights to a patent portfolio covering the optimization of the stem cell differentiation selection process and the use of heart cells in drug testing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.